Salix Announces 2021 Gastrointestinal Health Scholars Program Winners
LAVAL, Quebec, July 22, 2021 /PRNewswire/ --Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, todayannounced the winners of its 2021 Salix Gastrointestinal Health Scholars Program.
- LAVAL, Quebec, July 22, 2021 /PRNewswire/ --Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, todayannounced the winners of its 2021 Salix Gastrointestinal Health Scholars Program.
- The 2021 Salix Gastrointestinal Health Scholars Program recipients are:
"I'm so grateful to receive this scholarship as I pursue my higher education in nursing school," said Madeleine Huwe, a recipient of the Undergraduate Scholar's Award. - To learn more about the Salix Gastrointestinal Health Scholars Program visit www.salix.com/scholarship .
- The 2022 Salix Gastrointestinal Health Scholars Award will begin accepting applications in early 2022.